Literature DB >> 22556043

An optimized velocity selective arterial spin labeling module with reduced eddy current sensitivity for improved perfusion quantification.

James A Meakin1, Peter Jezzard.   

Abstract

Velocity-selective (VS) arterial spin labeling is a promising method for measuring perfusion in areas of slow or collateral flow by eliminating the bolus arrival delay associated with other spin labeling techniques. However, B(0) and B(1) inhomogeneities and eddy currents during the VS preparation hinder accurate quantification of perfusion with VS arterial spin labeling. In this study, it is demonstrated through simulations and experiments in healthy volunteers that eddy currents cause erroneous tagging of static tissue. Consequently, mean gray matter perfusion is overestimated by up to a factor of 2, depending on the VS preparation used. A novel eight-segment B(1) insensitive rotation VS preparation is proposed to reduce eddy current effects while maintaining the B(0) and B(1) insensitivity of previous preparations. Compared to two previous VS preparations, the eight-segment B(1) insensitive rotation is the most robust to eddy currents and should improve the quality and reliability of VS arterial spin labeling measurements in future studies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556043     DOI: 10.1002/mrm.24302

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  15 in total

1.  Cerebral blood volume mapping using Fourier-transform-based velocity-selective saturation pulse trains.

Authors:  Qin Qin; Yaoming Qu; Wenbo Li; Dapeng Liu; Taehoon Shin; Yansong Zhao; Doris D Lin; Peter C M van Zijl; Zhibo Wen
Journal:  Magn Reson Med       Date:  2019-02-08       Impact factor: 4.668

Review 2.  Arterial spin labeling for the measurement of cerebral perfusion and angiography.

Authors:  Peter Jezzard; Michael A Chappell; Thomas W Okell
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-23       Impact factor: 6.200

Review 3.  Recent progress in ASL.

Authors:  Luis Hernandez-Garcia; Anish Lahiri; Jonas Schollenberger
Journal:  Neuroimage       Date:  2018-01-03       Impact factor: 6.556

4.  Quantitative measurement of cerebral blood volume using velocity-selective pulse trains.

Authors:  Dexiang Liu; Feng Xu; Doris D Lin; Peter C M van Zijl; Qin Qin
Journal:  Magn Reson Med       Date:  2016-10-31       Impact factor: 4.668

5.  Placental perfusion imaging using velocity-selective arterial spin labeling.

Authors:  Zungho Zun; Catherine Limperopoulos
Journal:  Magn Reson Med       Date:  2018-02-13       Impact factor: 4.668

6.  Improved velocity-selective-inversion arterial spin labeling for cerebral blood flow mapping with 3D acquisition.

Authors:  Dapeng Liu; Feng Xu; Wenbo Li; Peter C van Zijl; Doris D Lin; Qin Qin
Journal:  Magn Reson Med       Date:  2020-05-13       Impact factor: 4.668

7.  Velocity-selective-inversion prepared arterial spin labeling.

Authors:  Qin Qin; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2015-10-28       Impact factor: 4.668

8.  Improved sensitivity and temporal resolution in perfusion FMRI using velocity selective inversion ASL.

Authors:  Luis Hernandez-Garcia; Jon-Fredrik Nielsen; Douglas C Noll
Journal:  Magn Reson Med       Date:  2018-09-06       Impact factor: 4.668

9.  Ensuring both velocity and spatial responses robust to B 0 / B 1 + field inhomogeneities for velocity-selective arterial spin labeling through dynamic phase-cycling.

Authors:  Dapeng Liu; Wenbo Li; Feng Xu; Dan Zhu; Taehoon Shin; Qin Qin
Journal:  Magn Reson Med       Date:  2020-12-08       Impact factor: 4.668

10.  Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.

Authors:  Yaoming Qu; Dexia Kong; Haitao Wen; Xiaochan Ou; Qihong Rui; Xianlong Wang; Doris D Lin; Qin Qin; Zhibo Wen
Journal:  Eur Radiol       Date:  2022-01-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.